Q: Hello, what are your thoughts on the news regarding a bid for Aetna? Stock is down quite a bit over the past year. I had initially had a 5% weighting, thinking about buying more on the price weakness, Thank you!
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Any comments on reactions to news items following the private financing?
Q: I have small position in CELG (about 2%). With the recent weakness in the last week, would you suggest holding onto it, or even buying more? If I were to sell is there another healthcare stock you would suggest?
Q: I use this ETF to provide proper exposure to healthcare within my portfolio. Now it is under pressure as a result of political pressure. Would this be a good time to take profits?
Q: Savaria reports earnings on Nov.8.
What is the outlook? How often did they miss earnings in the past?
Thank you very much.
What is the outlook? How often did they miss earnings in the past?
Thank you very much.
Q: Hi Team,
GSK has been down to 5 year low @$36.52 today. Your comment about pick up some for medium-term hold ?
Thanks as always,
Tak
GSK has been down to 5 year low @$36.52 today. Your comment about pick up some for medium-term hold ?
Thanks as always,
Tak
Q: Hello...your view today on PLI please as a purely speculative purchase...
Q: Could I get your opinion on Amarin, a small cap biotech stock?
Q: You were right about CXR.
I was reading recently that their earnings were improving some and hoping for a small bump before dumping my remaining shares. Looks like I asked one day too late.
Paul
I was reading recently that their earnings were improving some and hoping for a small bump before dumping my remaining shares. Looks like I asked one day too late.
Paul
Q: Is this a good opportunity at this time for a two year hold?
Q: I know you don't cover American stocks but was wondering if I could get your opinion on RAD.
Q: If I may follow up to today's question about celgene; how does the lack of a dividend paid by celgene bring you to recommend against moving towards a 5% position?
Can you please explain your rationale?
Most growth stock do not pay dividends, yet you have in the passed given the 'ok' for full position ( goog, fb)
Thank you
Karim
Can you please explain your rationale?
Most growth stock do not pay dividends, yet you have in the passed given the 'ok' for full position ( goog, fb)
Thank you
Karim
Q: It appears that what Peter has anticipated for CXR is about to occur. Financial Post reported earlier today, in part: "Following previous efforts to retool its capital structure, Concordia is beginning a court proceeding under the Canada Business Corporations Act (CBCA). The company hopes to reduce its existing secured and unsecured debt obligations by more than $2 billion."
Q: I currently own a 3.5 % position in celgene. Yesterday's accouncement of a failure to proceed to a phase 3 drug trial has led to two analyst downgrades. The stock is down 6 percent pre market. Would you be comfortable, at this moment, to top up to 5%? Or do you see more downside for the company, and would prefer to let things settle.
Thank you
Karim
Thank you
Karim
Q: I know you're not a fan of the above stock, but I believe the earnings report is coming in early November. Does it look like it may improve for the next report or is more bad news coming?
thanks, Paul
thanks, Paul
Q: They seem to have bottomed out and are now moving up on increased volume
Would this be a time to enter a small position
Tfsa and ok with risk
Thank you
Would this be a time to enter a small position
Tfsa and ok with risk
Thank you
Q: Any updated comments now that they are FDA approved?
Q: Any reason for today's drop in the share price? Obamacare news?Thank you!
Q: A two part question so do dock me two credits:
1. GUD: just about of patience with this stock which is down 18% this year. I know Goodman's reputation, and they have plenty of cash, and it took Paladin a long time to pay off, but sales are minimal, and more significantly, there doesn't appear to be much going on. Can you give me a plausible reason to hang in?
2. Other than the REITS - csh, exe, nwh - and your fave SIS, is there anything worth considering in this sector in Canada, or should I turn to the U.S.? Tecsys is technically in the Tech sector but could you reasonably consider it a healthcare stock?
Thanks!
1. GUD: just about of patience with this stock which is down 18% this year. I know Goodman's reputation, and they have plenty of cash, and it took Paladin a long time to pay off, but sales are minimal, and more significantly, there doesn't appear to be much going on. Can you give me a plausible reason to hang in?
2. Other than the REITS - csh, exe, nwh - and your fave SIS, is there anything worth considering in this sector in Canada, or should I turn to the U.S.? Tecsys is technically in the Tech sector but could you reasonably consider it a healthcare stock?
Thanks!
Q: The last question about TCS was in July. Since then the stock has been on a tear. I am thinking about swapping out GUD and DR for TCS - I know TCS is considered tech - but I am looking at it as a quasi healthcare pick. Thanks for your current views.